Search research articles
Contact Us
Filters
Showing results (41-50 of 127) with videos related to
Page
of 13
Sort By:
European Journal of Endocrinology
|
September 9, 2011
Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
Raghava Reddy, Simon Cudlip, James V Byrne, et al.
Clinical Endocrinology
|
September 7, 2007
Wide variation in surgical outcomes for acromegaly in the UK
P R Bates, M N Carson, P J Trainer, et al.
Pituitary
|
November 15, 2007
Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
Alberto Fernandez, Niki Karavitaki, Olaf Ansorge, et al.
Clinical Endocrinology
|
September 29, 2011
Rathke's cleft cysts
Raluca Trifanescu, Olaf Ansorge, John A H Wass, et al.
The American Journal of Medicine
|
June 1, 1983
Portal and pulmonary hypertension with microangiopathic hemolytic anemia
P D Paré, C Chan-Yan, H Wass, et al.
Clinical Endocrinology
|
December 11, 2012
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
Niki Karavitaki, Ruxandra Dobrescu, James V Byrne, et al.
Clinical Endocrinology
|
February 19, 2002
Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit
L B Yap, H E Turner, C B T Adams, et al.
Clinical Endocrinology
|
February 25, 2009
GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence
J R Arnold, D F Arnold, A Marland, et al.
Endocrine-Related Cancer
|
September 7, 2006
Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour
N Garcia de la Torre, I Buley, J A H Wass, et al.
Clinical Endocrinology
|
April 12, 2013
Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
Trevor A Howlett, Debbie Willis, Gillian Walker, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 127) with videos related to
Sort By:
Page
of 13
European Journal of Endocrinology
|
September 9, 2011
Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
Raghava Reddy, Simon Cudlip, James V Byrne, et al.
Clinical Endocrinology
|
September 7, 2007
Wide variation in surgical outcomes for acromegaly in the UK
P R Bates, M N Carson, P J Trainer, et al.
Pituitary
|
November 15, 2007
Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
Alberto Fernandez, Niki Karavitaki, Olaf Ansorge, et al.
Clinical Endocrinology
|
September 29, 2011
Rathke's cleft cysts
Raluca Trifanescu, Olaf Ansorge, John A H Wass, et al.
The American Journal of Medicine
|
June 1, 1983
Portal and pulmonary hypertension with microangiopathic hemolytic anemia
P D Paré, C Chan-Yan, H Wass, et al.
Clinical Endocrinology
|
December 11, 2012
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
Niki Karavitaki, Ruxandra Dobrescu, James V Byrne, et al.
Clinical Endocrinology
|
February 19, 2002
Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit
L B Yap, H E Turner, C B T Adams, et al.
Clinical Endocrinology
|
February 25, 2009
GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence
J R Arnold, D F Arnold, A Marland, et al.
Endocrine-Related Cancer
|
September 7, 2006
Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour
N Garcia de la Torre, I Buley, J A H Wass, et al.
Clinical Endocrinology
|
April 12, 2013
Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
Trevor A Howlett, Debbie Willis, Gillian Walker, et al.
Page
of 13